focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.50
Bid: 54.48
Ask: 54.50
Change: -0.04 (-0.07%)
Spread: 0.02 (0.037%)
Open: 54.76
High: 54.80
Low: 54.26
Prev. Close: 54.54
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bank of England Stress Test Passed

16 Dec 2019 17:52

RNS Number : 0585X
Lloyds Banking Group PLC
16 December 2019
 

 

16 December 2019

LLOYDS BANKING GROUP PASSES BANK OF ENGLAND STRESS TEST

Lloyds Banking Group (the Group), together with six other financial institutions in the UK, has been subject to the 2019 stress test conducted by the Bank of England (BoE).

 

This year's stress test scenario is broadly the same as the last two years and is the most severe test that the Group has faced and more severe than the last global financial crisis. The scenario combines rapidly rising interest rates and unemployment, in conjunction with significant falls in property prices and GDP. In particular, base rates rise to 4 per cent in the first year and remain at this level for a further three years, GDP reduces by 4.7 per cent in the first year, unemployment increases to a peak of 9.2 per cent in the second year, and UK house and commercial property prices fall 33 per cent and 41 per cent, respectively over the first three years. In addition to these economic factors, and in line with previous years, the stress test also reflects other risks including conduct. 

 

In line with 2018, this year's stress test runs under the IFRS 9 accounting standard and requires the immediate recognition of expected losses on a perfect foresight basis, rather than reflecting incurred losses. The BoE assesses the stress test results on an IFRS 9 transitional basis, in line with the phased implementation approach. Results are also shown on an IFRS 9 fully-loaded basis.

 

Result of the stress test

The Group has passed the stress test on a transitional basis with the BoE calculating the Group's transitional CET1 ratio after the application of management actions as 8.5 per cent and its leverage ratio as 4.3 per cent against the hurdle rates of 7.5 per cent and 3.47 per cent, respectively. Despite the severity of the stress test scenario, the Group exceeds the capital and leverage hurdles after the application of management actions. Given this performance, the Group is not required to take any capital actions.

 

The Group's capital position remains strong having reported a CET1 ratio of 13.5 per cent and a leverage ratio of 4.9 per cent, post dividend accrual, at 30 September 2019. The Group also continues to be strongly capital generative with free capital build for the first nine months of the year of 149 bps pre PPI.

 

Further details

Details of the BoE's approach to the stress test and the detailed results in relation to all participating financial institutions are available from the BoE website.

 

For further information:

 

Investor Relations

Douglas Radcliffe +44 (0) 20 7356 1571

Group Investor Relations Director

douglas.radcliffe@lloydsbanking.com

 

 

Corporate Affairs

Matt Smith +44 (0) 20 7356 3522

Head of Media Relations

matt.smith@lloydsbanking.com 

 

 

 

FORWARD LOOKING STATEMENTS

This document contains certain forward looking statements with respect to the business, strategy, plans and/or results of the Group and its current goals and expectations relating to its future financial condition and performance. Statements that are not historical facts, including statements about the Group's or its directors' and/or management's beliefs and expectations, are forward looking statements. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend upon circumstances that will or may occur in the future. Factors that could cause actual business, strategy, plans and/or results (including but not limited to the payment of dividends) to differ materially from forward looking statements made by the Group or on its behalf include, but are not limited to: general economic and business conditions in the UK and internationally; market related trends and developments; fluctuations in interest rates, inflation, exchange rates, stock markets and currencies; any impact of the transition from IBORs to alternative reference rates; the ability to access sufficient sources of capital, liquidity and funding when required; changes to the Group's credit ratings; the ability to derive cost savings and other benefits including, but without limitation as a result of any acquisitions, disposals and other strategic transactions; the ability to achieve strategic objectives; changing customer behaviour including consumer spending, saving and borrowing habits; changes to borrower or counterparty credit quality; concentration of financial exposure; management and monitoring of conduct risk; instability in the global financial markets, including Eurozone instability, instability as a result of uncertainty surrounding the exit by the UK from the European Union (EU) and as a result of such exit and the potential for other countries to exit the EU or the Eurozone and the impact of any sovereign credit rating downgrade or other sovereign financial issues; political instability including as a result of any UK general election; technological changes and risks to the security of IT and operational infrastructure, systems, data and information resulting from increased threat of cyber and other attacks; natural, pandemic and other disasters, adverse weather and similar contingencies outside the Group's control; inadequate or failed internal or external processes or systems; acts of war, other acts of hostility, terrorist acts and responses to those acts, geopolitical, pandemic or other such events; risks relating to climate change; changes in laws, regulations, practices and accounting standards or taxation, including as a result of the exit by the UK from the EU, or a further possible referendum on Scottish independence; changes to regulatory capital or liquidity requirements and similar contingencies outside the Group's control; the policies, decisions and actions of governmental or regulatory authorities or courts in the UK, the EU, the US or elsewhere including the implementation and interpretation of key legislation and regulation together with any resulting impact on the future structure of the Group; the ability to attract and retain senior management and other employees and meet its diversity objectives; actions or omissions by the Group's directors, management or employees including industrial action; changes to the Group's post-retirement defined benefit scheme obligations; the extent of any future impairment charges or write-downs caused by, but not limited to, depressed asset valuations, market disruptions and illiquid markets; the value and effectiveness of any credit protection purchased by the Group; the inability to hedge certain risks economically; the adequacy of loss reserves; the actions of competitors, including non-bank financial services, lending companies and digital innovators and disruptive technologies; and exposure to regulatory or competition scrutiny, legal, regulatory or competition proceedings, investigations or complaints. Please refer to the latest Annual Report on Form 20-F filed with the US Securities and Exchange Commission for a discussion of certain factors and risks together with examples of forward looking statements. Except as required by any applicable law or regulation, the forward looking statements contained in this document are made as of today's date, and the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained in this document to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. The information, statements and opinions contained in this document do not constitute a public offer under any applicable law or an offer to sell any securities or financial instruments or any advice or recommendation with respect to such securities or financial instruments.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFSDFDLRLIA
Date   Source Headline
5th Jan 20241:50 pmRNSPublication of Final Terms
2nd Jan 202412:00 pmRNSBlock listing Interim Review
29th Dec 202310:30 amRNSTotal Voting Rights
18th Dec 20232:30 pmRNSBoard Committee Change
18th Dec 20232:00 pmRNSDirector/PDMR Shareholding
12th Dec 20234:00 pmRNSDirector/PDMR Shareholding
30th Nov 20232:00 pmRNSTotal Voting Rights
20th Nov 20232:00 pmRNSBlock Listing of Shares
10th Nov 20234:00 pmRNSDirector/PDMR Shareholding
6th Nov 20233:57 pmRNSPublication of Final Terms
31st Oct 202311:20 amRNSTotal Voting Rights
26th Oct 20233:47 pmRNSPublication of Suppl.Prospcts
26th Oct 20231:02 pmRNSPublication of Suppl.Prospcts
26th Oct 202312:59 pmRNSPublication of Suppl.Prospcts - Correction
25th Oct 202312:09 pmRNSPublication of Suppl.Prospcts
25th Oct 202311:57 amRNS2023 Q3 Interim Management Statement
25th Oct 20237:00 amRNS2023 Q3 Interim Management Statement
11th Oct 20232:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20232:00 pmRNSDirector/PDMR Shareholding
21st Sep 20231:28 pmRNSPublication of Final Terms
20th Sep 20232:00 pmRNSDirector/PDMR Shareholding
15th Sep 20232:00 pmRNSDirector/PDMR Shareholding
13th Sep 20232:00 pmRNSBoard and Committee changes
13th Sep 20231:45 pmRNSDirector/PDMR Shareholding
13th Sep 20239:20 amRNS2023 Half-Year Results
31st Aug 202312:00 pmRNSTotal Voting Rights
29th Aug 20237:21 amRNSCompletion of £2 billion Share Buyback Programme
25th Aug 20235:51 pmRNSTransaction in Own Shares
24th Aug 20235:38 pmRNSTransaction in Own Shares
24th Aug 20235:30 pmRNSTotal Voting Rights
23rd Aug 20235:21 pmRNSTransaction in Own Shares
22nd Aug 20235:18 pmRNSTransaction in Own Shares
22nd Aug 202311:44 amRNSPublication of Pricing Supplement
22nd Aug 20239:39 amRNSStabilisation Notice
21st Aug 20235:14 pmRNSTransaction in Own Shares
18th Aug 20235:37 pmRNSTransaction in Own Shares
17th Aug 20235:39 pmRNSTransaction in Own Shares
16th Aug 20235:29 pmRNSTransaction in Own Shares
15th Aug 20235:28 pmRNSTransaction in Own Shares
14th Aug 20235:36 pmRNSTransaction in Own Shares
11th Aug 20235:49 pmRNSTransaction in Own Shares
10th Aug 20235:42 pmRNSTransaction in Own Shares
10th Aug 20232:00 pmRNSDirector/PDMR Shareholding
9th Aug 20235:41 pmRNSTransaction in Own Shares
8th Aug 20235:29 pmRNSTransaction in Own Shares
7th Aug 20236:04 pmRNSTransaction in Own Shares
4th Aug 20235:19 pmRNSTransaction in Own Shares
3rd Aug 20235:28 pmRNSTransaction in Own Shares
31st Jul 20235:36 pmRNSTransaction in Own Shares
31st Jul 20234:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.